Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297,730 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance.
Ashrafizadeh M, Saebfar H, Gholami MH, Hushmandi K, Zabolian A, Bikarannejad P, Hashemi M, Daneshi S, Mirzaei S, Sharifi E, Kumar AP, Khan H, Heydari Sheikh Hossein H, Vosough M, Rabiee N, Kumar Thakur V, Makvandi P, Mishra YK, Tay FR, Wang Y, Zarrabi A, Orive G, Mostafavi E. Ashrafizadeh M, et al. Among authors: wang y. Expert Opin Drug Deliv. 2022 Apr;19(4):355-382. doi: 10.1080/17425247.2022.2041598. Epub 2022 Apr 3. Expert Opin Drug Deliv. 2022. PMID: 35152815
Long non-coding RNAs in the doxorubicin resistance of cancer cells.
Ashrafizaveh S, Ashrafizadeh M, Zarrabi A, Husmandi K, Zabolian A, Shahinozzaman M, Aref AR, Hamblin MR, Nabavi N, Crea F, Wang Y, Ahn KS. Ashrafizaveh S, et al. Among authors: wang y. Cancer Lett. 2021 Jun 28;508:104-114. doi: 10.1016/j.canlet.2021.03.018. Epub 2021 Mar 22. Cancer Lett. 2021. PMID: 33766750 Review.
The long and short non-coding RNAs modulating EZH2 signaling in cancer.
Mirzaei S, Gholami MH, Hushmandi K, Hashemi F, Zabolian A, Canadas I, Zarrabi A, Nabavi N, Aref AR, Crea F, Wang Y, Ashrafizadeh M, Kumar AP. Mirzaei S, et al. Among authors: wang y. J Hematol Oncol. 2022 Mar 2;15(1):18. doi: 10.1186/s13045-022-01235-1. J Hematol Oncol. 2022. PMID: 35236381 Free PMC article. Review.
Correction: The long and short non-coding RNAs modulating EZH2 signaling in cancer.
Mirzaei S, Gholami MH, Hushmandi K, Hashemi F, Zabolian A, Canadas I, Zarrabi A, Nabavi N, Aref AR, Crea F, Wang Y, Ashrafizadeh M, Kumar AP. Mirzaei S, et al. Among authors: wang y. J Hematol Oncol. 2022 May 6;15(1):50. doi: 10.1186/s13045-022-01276-6. J Hematol Oncol. 2022. PMID: 35524266 Free PMC article. No abstract available.
Long noncoding RNAs (lncRNAs) in pancreatic cancer progression.
Ashrafizadeh M, Rabiee N, Kumar AP, Sethi G, Zarrabi A, Wang Y. Ashrafizadeh M, et al. Among authors: wang y. Drug Discov Today. 2022 Aug;27(8):2181-2198. doi: 10.1016/j.drudis.2022.05.012. Epub 2022 May 16. Drug Discov Today. 2022. PMID: 35589014 Review.
Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention.
Mirzaei S, Paskeh MDA, Okina E, Gholami MH, Hushmandi K, Hashemi M, Kalu A, Zarrabi A, Nabavi N, Rabiee N, Sharifi E, Karimi-Maleh H, Ashrafizadeh M, Kumar AP, Wang Y. Mirzaei S, et al. Among authors: wang y. J Exp Clin Cancer Res. 2022 Jul 1;41(1):214. doi: 10.1186/s13046-022-02406-1. J Exp Clin Cancer Res. 2022. PMID: 35773731 Free PMC article. Review.
(Nano)platforms in bladder cancer therapy: Challenges and opportunities.
Ashrafizadeh M, Zarrabi A, Karimi-Maleh H, Taheriazam A, Mirzaei S, Hashemi M, Hushmandi K, Makvandi P, Nazarzadeh Zare E, Sharifi E, Goel A, Wang L, Ren J, Nuri Ertas Y, Kumar AP, Wang Y, Rabiee N, Sethi G, Ma Z. Ashrafizadeh M, et al. Among authors: wang l, wang y. Bioeng Transl Med. 2022 Jun 17;8(1):e10353. doi: 10.1002/btm2.10353. eCollection 2023 Jan. Bioeng Transl Med. 2022. PMID: 36684065 Free PMC article. Review.
297,730 results
You have reached the last available page of results. Please see the User Guide for more information.